Centene Corporation faces high costs and near-term profitability challenges, but offers significant long-term upside if margins recover. CNC's Q3 earnings are expected to be volatile, with revenue ...
Centene, a leading health insurer, shows strong fundamentals and growth despite sector challenges, making it a "Buy" at a target price of $70/share. The company’s 2Q24 results indicate robust earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback